Cargando…
Evaluation safety and efficacy of immune checkpoint blockers (ICB) and radiotherapy combination versus ICB in non‐small cell lung cancer patients with recurrence or metastasis: A systematic review and meta‐analysis
BACKGROUND: Currently, immune checkpoint blockers (ICB) and radiotherapy (RT) combination therapy is broadly applied in non‐small cell lung cancer (NSCLC) patients. However, meta‐analysis about safety and efficacy of RT + ICB versus ICB has not yet been reported. To evaluate safety and efficacy of t...
Autores principales: | Zeng, Yichun, Zhang, Liying, Liang, Yichen, Zhang, Xian, Li, Lei, Wang, Maoqi, Guo, Jingliang, Li, Qiuxian, Cao, Jin, Gu, Juan J., Wang, Buhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358264/ https://www.ncbi.nlm.nih.gov/pubmed/37323098 http://dx.doi.org/10.1002/cam4.5958 |
Ejemplares similares
-
IPMA-D based on ICB 4 courseware
por: Hermarij, John
Publicado: (2017) -
MAOI Antidepressants: Could They Be a Next-Generation ICB Therapy?
por: Brown, James, et al.
Publicado: (2022) -
Epitranscriptomic Approach: To Improve the Efficacy of ICB Therapy by Co-Targeting Intracellular Checkpoint CISH
por: Kumar, Sunil, et al.
Publicado: (2021) -
The Chemokines Initiating and Maintaining Immune Hot Phenotype Are Prognostic in ICB of HNSCC
por: Huang, Yuhong, et al.
Publicado: (2022) -
A new ICB sister journal focuses on clinical and translational immunology
por: Belz, Gabrielle, et al.
Publicado: (2012)